Lotan, R. et al. Suppression of retinoic acid receptor-β in premalignant oral lesions and its up-regulation by isotretinoin. N. Engl. J. Med. 332, 1405–1410 (1995).
Hong, W.K. et al. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N. Engl. J. Med. 323, 795–801 (1990).
Rubin Grandis, J. & Tweardy, D.T. Elevated levels of transforming growth factor-α and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res. 53, 3579–3584 (1993).
Field, J.K. et al. Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene 4, 1463–1468 (1989).
Boyle, J.O. et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 53, 4477–4480 (1993).
Todd, R. et al. TGF-α and EGF receptor mRNA in human oral cancers. Carcinogenesis 10, 1553–1556 (1989).
Williams, M.E. et al. Chromosome 11ql3 amplification in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 119, 1238–1243 (1993).
Maestro, R. et al. Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res. 53, 5775–5779 (1993).
Nawroz, H. et al. Allelotype of head and neck squamous cell carcinoma. Cancer Res. 54, 1152–1155 (1994).
Schuuring, E., Verhoeven, E., Mooi, W.J. & Michalides, R.J. Identification and cloning of two overexpressed genes U21B31/PRD 1 and EMS 1, within the amplified chromosome 11ql3 region in human carcinomas. Oncogene 7, 355–361 (1992).
Callender, T. et al. PRAD-1 (CCNDl)/Cyclin Dl oncogene amplification in primary head and neck squamous cell carcinomas. Cancer 74, 152–158 (1994).
Warrell, R.P., Jr., de The, H., Wang, Z.Y. & Dego, S.L. Acute promyelocytic leukemia. N. Engl. J. Med. 329, 177–189 (1993).
Mangelsdorf, D.J., Ong, E.S., Dyck, J.A. & Evans, R.M. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345, 224–229 (1990).
Stellmach, V., Leask, A. & Fuchs, E. Retinoid-mediated transcriptional regulation of keratin genes in human epidermal and squamous cell carcinoma cells. Proc. Natl. Acad. Sci. USA 88, 4582–4586 (1991).
Kim, J.S. et al. Suppression by retinoic acid of epidermal growth factor receptor autophosphorylation and glycosylation in cultured human head and neck squamous carcinoma cells. J. Natl. Cancer Inst. Monogr. 13, 101–110 (1992).
Zheng, Z.S. & Goldsmith, L.A. Modulation of epidermal growth factor receptors by retinoic acid in ME180 cells. Cancer Res. 50, 1201–1205 (1990).
Jetten, A.M. et al. Inhibition of growth and squamous cell differentiation markers in cultured human head and neck squamous carcinoma cells by β-all-trans retinoic acid. Int. J. Cancer 45, 195–202 (1990).
Sacks, P.G., Oke, V., Amos, B., Vasey, T. & Lotan, R. Modulation of growth, differentiation and glycoprotein synthesis by β-all-trans retinoic acid in a multicellular tumor spheroid model for squamous carcinoma of the head and neck. Int. J. Cancer 44, 926–933 (1989).
Dmitrovsky, E., Moy, D., Miller, W.H., Li, A. & Masui, H. Retinoic acid causes a decline in TGF-α expression, cloning efficiency, and tumorigenicity in a human embryonal cancer cell line. Oncogene Res 5, 233–239 (1990).
Garewal, H.S. et al. Response of oral leukoplakia to β-carotene. J. Clin. Oncol. 8, 1715–1720 (1990).